Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) VP Elizabeth D. Phillips sold 1,850 shares of the company's stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total value of $100,214.50. Following the sale, the vice president now owns 13,591 shares of the company's stock, valued at $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Kewaunee Scientific Stock Down 1.3 %
Kewaunee Scientific stock traded down $0.72 during trading on Wednesday, reaching $53.03. 13,103 shares of the company's stock were exchanged, compared to its average volume of 17,233. Kewaunee Scientific Co. has a 52-week low of $24.49 and a 52-week high of $56.95. The firm has a market cap of $152.30 million, a price-to-earnings ratio of 8.40 and a beta of 0.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The company's 50-day moving average is $38.92 and its two-hundred day moving average is $42.40.
Analysts Set New Price Targets
Separately, StockNews.com upgraded shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Wednesday.
Check Out Our Latest Research Report on KEQU
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of KEQU. Barclays PLC purchased a new stake in shares of Kewaunee Scientific during the 3rd quarter valued at about $121,000. Geode Capital Management LLC raised its stake in shares of Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after purchasing an additional 1,941 shares during the period. State Street Corp acquired a new position in shares of Kewaunee Scientific during the third quarter worth $266,000. De Lisle Partners LLP boosted its stake in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock valued at $1,446,000 after purchasing an additional 11,511 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock valued at $363,000 after purchasing an additional 2,156 shares during the period. Institutional investors and hedge funds own 32.69% of the company's stock.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
